information is currency- Top See results about

 Robot concept stocks are active again and again, and Great Wheel Intelligence, Ningbo Jingda, Kelier and Keli Sensing have reached new heights.Zhewen Internet: Zhejiang Internet (600986) announced on the evening of December 11th that the company intends to authorize the management of the company to make an independent decision to dispose of the stock of Doushen Education Technology (Beijing) Co., Ltd. (hereinafter referred to as "Doushen Education") held by the company through centralized bidding or block trading. The authorization period is within 36 months from the date of deliberation and approval by the shareholders' meeting. As of the date of announcement, the company holds 61.06 million shares of Doushen Education, accounting for 2.95% of the total share capital of Doushen Education, and will lift the restriction on sales on December 29, 2024.

On the first anniversary of listing, the index of Morgan Standard & Poor's Hong Kong Stock Connect low-wave dividend ETF has risen by more than 20% in the past year. Since the beginning of this year, the performance of high dividend assets in Hong Kong stocks has been eye-catching, which has driven the relevant dividend index to strengthen. Wind data shows that as of December 10th, the low-wave dividend index of S&P Hong Kong Stock Connect rose by 27.16% in the past year, significantly exceeding the increase of 12.01% in the CSI dividend index and 17.76% in the CSI dividend low volatility index. As the only ETF tracking the low-wave dividend index of S&P Hong Kong Stock Connect in China, it is also the largest ETF of its kind. Morgan S&P Hong Kong Stock Connect Low-wave dividend ETF(513630) may become the preferred configuration for many investors. (CSI)The concept of humanoid robot is active again and again. Wuzhou New Year, Hanyu Group have daily limit, while the concept of humanoid robot is active again and again. Wuzhou New Year, Hanyu Group, Astar, Fenda Technology have daily limit, and Keli Sensing and Tianyue Mathematics have followed up.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.

Meifeng, Sichuan: The wellhead natural gas trial production and recovery project has entered the trial production stage. meifeng, Sichuan announced that the trial production and recovery project of "Jinshi 103 Well" invested and built by Dongcai Shuangrui has completed the joint commissioning, and the trial production LNG products meet the requirements of national standards and are now entering the trial production stage. The total investment of the project is about 70 million yuan, and the main construction content is a set of wellhead gas trial production recovery device with a daily processing capacity of 200,000 m and supporting utilities and auxiliary facilities.Meifeng, Sichuan: The wellhead natural gas trial production and recovery project has entered the trial production stage. meifeng, Sichuan announced that the trial production and recovery project of "Jinshi 103 Well" invested and built by Dongcai Shuangrui has completed the joint commissioning, and the trial production LNG products meet the requirements of national standards and are now entering the trial production stage. The total investment of the project is about 70 million yuan, and the main construction content is a set of wellhead gas trial production recovery device with a daily processing capacity of 200,000 m and supporting utilities and auxiliary facilities.Jiangsu Guoxin: Guoxin Bindian's 1000MW unit was officially put into production. Jiangsu Guoxin announced that a 1000MW secondary reheat ultra-supercritical coal-fired generator set newly built by its holding subsidiary Guoxin Bindian completed its 168-hour full-load trial operation and was officially put into operation on December 11, 2024.